164 related articles for article (PubMed ID: 33813137)
1. A circular network of coregulated sphingolipids dictates lung cancer growth and progression.
Meng Q; Hu X; Zhao X; Kong X; Meng YM; Chen Y; Su L; Jiang X; Qiu X; Huang C; Liu C; Wang M; Wong PP
EBioMedicine; 2021 Apr; 66():103301. PubMed ID: 33813137
[TBL] [Abstract][Full Text] [Related]
2. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
[TBL] [Abstract][Full Text] [Related]
3. Synaptotagmin 7 in twist-related protein 1-mediated epithelial - Mesenchymal transition of non-small cell lung cancer.
Liu X; Li C; Yang Y; Liu X; Li R; Zhang M; Yin Y; Qu Y
EBioMedicine; 2019 Aug; 46():42-53. PubMed ID: 31395502
[TBL] [Abstract][Full Text] [Related]
4. Effect of miR‑146a‑5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation.
Huang WT; Cen WL; He RQ; Xie Y; Zhang Y; Li P; Gan TQ; Chen G; Hu XH
Mol Med Rep; 2017 Dec; 16(6):8781-8792. PubMed ID: 28990079
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-520c-3p impacts sphingolipid metabolism mediating PI3K/AKT signaling in NSCLC: Systems perspective.
Gulhane P; Singh S
J Cell Biochem; 2022 Nov; 123(11):1827-1840. PubMed ID: 35977046
[TBL] [Abstract][Full Text] [Related]
6. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p.
Wei S; Zheng Y; Jiang Y; Li X; Geng J; Shen Y; Li Q; Wang X; Zhao C; Chen Y; Qian Z; Zhou J; Li W
EBioMedicine; 2019 Jun; 44():182-193. PubMed ID: 31160270
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective.
Gao X; Cai Y; Wang Z; He W; Cao S; Xu R; Chen H
J Transl Med; 2019 Sep; 17(1):308. PubMed ID: 31511014
[TBL] [Abstract][Full Text] [Related]
8. INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer.
Zhang S; Zhou B; Wang L; Li P; Bennett BD; Snyder R; Garantziotis S; Fargo DC; Cox AD; Chen L; Hu G
Oncogene; 2017 Mar; 36(10):1430-1439. PubMed ID: 27641337
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA sequencing reveals aberrant sphingolipid metabolism in non-small cell lung cancer impacts tumor-associated macrophages and stimulates angiogenesis via macrophage inhibitory factor signaling.
Shen L; Liu J; Hu F; Fang Y; Wu Y; Zhao W; Ma S
Thorac Cancer; 2024 May; 15(14):1164-1175. PubMed ID: 38587042
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma.
Porubsky S; Nientiedt M; Kriegmair MC; Siemoneit JH; Sandhoff R; Jennemann R; Borgmann H; Gaiser T; Weis CA; Erben P; Hielscher T; Popovic ZV
Sci Rep; 2021 May; 11(1):10926. PubMed ID: 34035403
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis.
Tandon N; Goller K; Wang F; Soibam B; Gagea M; Jain AK; Schwartz RJ; Liu Y
EBioMedicine; 2019 Dec; 50():55-66. PubMed ID: 31761621
[TBL] [Abstract][Full Text] [Related]
12. ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1.
Yin J; Fu W; Dai L; Jiang Z; Liao H; Chen W; Pan L; Zhao J
Sci Rep; 2017 Jun; 7(1):4430. PubMed ID: 28667340
[TBL] [Abstract][Full Text] [Related]
13. Role of EIF4G1 network in non-small cell lung cancers (NSCLC) cell survival and disease progression.
Del Valle L; Dai L; Lin HY; Lin Z; Chen J; Post SR; Qin Z
J Cell Mol Med; 2021 Mar; 25(6):2795-2805. PubMed ID: 33539648
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression.
Lu KH; Li W; Liu XH; Sun M; Zhang ML; Wu WQ; Xie WP; Hou YY
BMC Cancer; 2013 Oct; 13():461. PubMed ID: 24098911
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
16. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
17. Elevation of EIF4G1 promotes non-small cell lung cancer progression by activating mTOR signalling.
Lu Y; Yu S; Wang G; Ma Z; Fu X; Cao Y; Li Q; Xu Z
J Cell Mol Med; 2021 Mar; 25(6):2994-3005. PubMed ID: 33523588
[TBL] [Abstract][Full Text] [Related]
18. Circulating Proteoglycan Endocan Mediates EGFR-Driven Progression of Non-Small Cell Lung Cancer.
Yang YC; Pan KF; Lee WJ; Chang JH; Tan P; Gu CC; Chang WM; Yang SF; Hsiao M; Hua KT; Chien MH
Cancer Res; 2020 Aug; 80(16):3292-3304. PubMed ID: 32561533
[TBL] [Abstract][Full Text] [Related]
19. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway.
Bai Y; Liu X; Qi X; Liu X; Peng F; Li H; Fu H; Pei S; Chen L; Chi X; Zhang L; Zhu X; Song Y; Wang Y; Meng S; Jiang T; Shao S
EBioMedicine; 2019 Apr; 42():311-325. PubMed ID: 30922965
[TBL] [Abstract][Full Text] [Related]
20. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
